Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (60)

« Back to Publications

A posttranslational proteomic survey of a single anatomically preserved human 20-week postconception brain.

Bandiera S. et al, (2026), J Anat

Developing Topics

Duisberg BFE. et al, (2025), Alzheimer S Dementia the Journal of the Alzheimer S Association, 21

Basic Science and Pathogenesis

Bertherat F. et al, (2025), Alzheimer S Dementia the Journal of the Alzheimer S Association, 21

Biomarkers

Abdallah A. et al, (2025), Alzheimer S Dementia the Journal of the Alzheimer S Association, 21

Unbiased CSF Proteomics in Patients With Idiopathic Normal Pressure Hydrocephalus to Identify Molecular Signatures and Candidate Biomarkers.

de Geus MB. et al, (2025), Neurology, 104

Brain MRI signatures across sex and CSF Alzheimer's disease biomarkers.

Cheng Y. et al, (2025), Brain Commun, 7

Immunoassay for pyruvate kinase M1/2 as an Alzheimer's biomarker in CSF.

de Geus MB. et al, (2025), Open Life Sci, 20

A compilation of reported alterations in the cerebrospinal fluid proteome in Alzheimer's disease.

de Geus MB. et al, (2025), Brain Commun, 7

Basic Science and Pathogenesis

Abey AS. et al, (2024), Alzheimer's & dementia : the journal of the Alzheimer's Association, 20

Author Correction: Location and function of TDP-43 in platelets, alterations in neurodegenerative diseases and arising considerations for current plasma biobank protocols.

Luthi-Carter R. et al, (2024), Sci Rep, 14

Location and function of TDP-43 in platelets, alterations in neurodegenerative diseases and arising considerations for current plasma biobank protocols.

Luthi-Carter R. et al, (2024), Sci Rep, 14

Plasma VEGFA and PGF impact longitudinal tau and cognition in preclinical Alzheimer's disease.

Yang H-S. et al, (2024), Brain, 147, 2158 - 2168

BERNN: Enhancing classification of Liquid Chromatography Mass Spectrometry data with batch effect removal neural networks.

Pelletier SJ. et al, (2024), Nat Commun, 15

Interrogation of the human cortical peptidome uncovers cell-type specific signatures of cognitive resilience against Alzheimer's disease.

Morgan GR. and Carlyle BC., (2024), Sci Rep, 14

Biological effects of sodium phenylbutyrate and taurursodiol in Alzheimer's disease.

Arnold SE. et al, (2024), Alzheimers Dement (N Y), 10

Load More